Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and reactivity to infant signals in mothers with postpartum depression
2022-000603-12Phase 2Active
- Sponsor
- Radboud University
- Start
- Apr 2022
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of oxytocin in postpartum depression (PPD), sponsored by Radboud University. Started Apr 2022; status: active.
02
Drugs
oxytocin
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on 2022-000603-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000603-12.